Pharmaceutically acceptable salts of sertraline and...

Details Pharmaceutically acceptable salts of sertraline and... Pharmaceutically acceptable salts of sertraline and...

2006-08-22

2006-08-22

Davis, Brian (Department: 1621)

Organic compounds -- part of the class 532-570 series

Organic compounds

Amino nitrogen containing

C514S647000

Reexamination Certificate

active

07094930

ABSTRACT:
The present invention is directed to certain pharmaceutically acceptable salts of the therapeutically potent selective serotonin reuptake inhibitor, sertraline:and pharmaceutical compositions thereof, wherein said salts are selected from the group consisting of the p-toluenesulfonic acid salt, the fumaric acid salt, the benzenesulfonic acid salt, the benzoic acid salt, the L-tartaric acid salt and the (−)-camphor-10-sulfonic acid salt.

REFERENCES:
patent: 6495721 (2002-12-01), Schwartz
patent: 6723878 (2004-04-01), Laitinen
patent: WO9901121 (1999-01-01), None
patent: WO0021521 (2000-04-01), None
Julius F. Remenar et al.: “Salt Selection and Simultaneous Polymorphism Assessment via High Throughput Crystallization: The Case of Sertraline”; Organic Process Research and Development, vol. 7, No. 6, Oct. 14, 2003, pp. 990-996; XP002277129 the whole document.

Affiliated with

Also associated with

Rating

Pharmaceutically acceptable salts of sertraline and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutically acceptable salts of sertraline and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutically acceptable salts of sertraline and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3662889